Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Servier acquires Edgewise’s muscular dystrophy business for up to $2.65 billion to drive neurology expansion

02/06/2026 Published by Pharma Biz

U.S. biotech developer Edgewise Therapeutics has entered into a definitive agreement to sell its muscular dystrophy drug candidate and related... Read more

Tags: #M&A

FDA approves Shionogi’s Xocova, establishing the first oral post-exposure preventative for COVID-19 in the US

02/06/2026 Published by Pharma Biz

The United States Food and Drug Administration (FDA) has granted formal regulatory approval to Shionogi’s antiviral medication, Xocova (ensitrelvir), specifically... Read more

Category: Uncategorized

Tags: #Global Trends

Vietnamese Government convenes meeting to consolidate food safety management apparatus into a single focal agency

02/06/2026 Published by Pharma Biz

On the afternoon of June 1, 2026, at the Government Headquarters, Member of the Secretariat of the Central Committee and... Read more

Category: Uncategorized

Tags: #Vietnam

Pharmacity secures profitability following comprehensive portfolio restructuring and AI integration

02/06/2026 Published by Pharma Biz

Speaking at the Vietnam Innovation Investment Forum (VIPC Summit) 2026 held on May 28 in Ho Chi Minh City, Deepanshu... Read more

Category: Uncategorized

Tags: #Vietnam

Pharmacity secures profitability following comprehensive portfolio restructuring and AI integration

02/06/2026 Published by Pharma Biz

Speaking at the Vietnam Innovation Investment Forum (VIPC Summit) 2026 held on May 28 in Ho Chi Minh City, Deepanshu... Read more

Category: Uncategorized

Tags: #Vietnam

Novartis’ experimental radiopharma therapy showcases clinical efficacy in advanced prostate cancer trial

01/06/2026 Published by Pharma Biz

Swiss pharmaceutical flagship Novartis announced Sunday that early-stage clinical data monitoring its experimental actinium-based radioligand candidate demonstrated pronounced anti-tumor activity... Read more

Category: Uncategorized

Tags: #Global Trends

J&J’s prostate cancer therapeutic Erleada significantly limits metastasis and mortality risks in late-stage registration trial

01/06/2026 Published by Pharma Biz

Healthcare conglomerate Johnson & Johnson (J&J) announced definitive clinical data from a pivotal late-stage Phase III trial showcasing that its... Read more

Category: Uncategorized

Tags: #Global Trends

Vietnam’s Drug Administration fines multiple pharmaceutical firms, issues nationwide recalls for non-compliant cosmetics

01/06/2026 Published by Pharma Biz

The Drug Administration of Vietnam, operating under the Ministry of Health, has issued a series of administrative sanctions against multiple... Read more

Category: Uncategorized

Tags: #Vietnam